Monographie - Levofolinate calcium

Son güncelleme :
19/11/2024

Levofolinate calcium

Kimyasal yapı

Ticari isim

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Calc Levof	İtalya
Calcium levofolinat	Avusturya
Elvorine	Belçika, Fas, Fransa, Lüksemburg
Folaxin	İspanya
Folinate EG	Belçika
Isovorin	Avusturya, Büyük Britanya, Danimarka, Finlandiya, İspanya, İsveç, İzlanda, Yunanistan
Levofolatino de calcio	Portekiz
Levofolene	İtalya

Kaynaklar : Levofolinate calcium

	tip	yayın
3	Dergi	Trissel LA, Martinez JF. Compatibility of amifostine with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 1995 ; 52: 2208-2212.
155	Dergi	Trissel LA, Martinez JF, Xu QA. Incompatibility of fluorouracil with leucovorin calcium or levoleucovorin calcium. Am J Health-Syst Pharm 1995 ; 52: 710-715.
1520	Laboratuar	Etude de stabilité des médicaments en Ecoflac® B Braun 2001
1914	Laboratuar	Pemetrexed (Alimta®) - Summary of Product Characteristics Eli Lilly 2016
2130	Dergi	Lokiec F, Amirault P, Bonnans H, Gauzan MF, Sauvage N, Santoni J. Stabilité du mélange 5-fluoro-uracil-acide fonique : influence des concentrations, du contenant et de la forme de l’acide folinique. Bull Cancer 1999 ; 86, 11: 946-954.
2181	Dergi	Milano G, Renée N. Etude de compatibilité physicochimique 5- fluoro-uracile (nouvelle préparation française) - acide folinique. Bull Cancer 1995 ; 82: 189-195.
2295	Laboratuar	Fosaprepitant (Emend®) - Summary of Product Characteristics Merck Sharp Dohme 2013
2361	Dergi	Lebitasy M, Hecq J.D, Athanassopoulos A, Vanbeckbergen D, Jamart J, Galanti L. Effect of freeze-thawing on the long-term stability of calcium levofolinate in 5% dextrose stored on polyolefin infusion bags. J Clin Pharm Ther 2009 ; 34, 4 : 423-428.
2531	Dergi	Sanogo S, Silimbani P, Gaggeri R, Masini C. Stability of calcium levofolinate reconstituted in syringes and diluted in NaCl 0.9% and glucose 5% polyolefin/ polyamide infusion bags. J Oncol Pharm Practice 2021 ; 27, 2: 288-296.
3369	Laboratuar	Levofolinate de sodium Medac - Résumé des caractéristiques du produits MEDAC France 2011
3523	Laboratuar	Ceftriaxone (Rocephin®) - Summary of Product Characteristics. Roche 2018
3546	Laboratuar	Cefamandole Flavelab - Résumé des caractéristiques du produit Panpharma SA 2007
3619	Laboratuar	Pamidronate (Pamidronate Actavis®) - Summary of Product Characteristics Wockhardt 2016
3621	Laboratuar	Phosphate dipotassique - Résumé des caractéristiques du produit Renaudin 2008
3662	Laboratuar	Foscavir (Foscarnet®) - Summary of Product Characteristics Clinigen 2014
3753	Laboratuar	Tedizolid phosphate (Sivextro®) - Summary of Product Characteristics Cubist Pharmaceuticals 2014
3838	Laboratuar	Magnesium Sulphate - Summary of Product Characteristics Martindale Pharmaceuticals Ltd 2007
3933	Laboratuar	Acide zolédronique - (Acide zoledronique Teva Pharma) - Résumé des caractéristiques du produit Teva Laboratoire 2015
4154	Laboratuar	Bleomycin sulfate- Summary of Product Characteristics Accord Health Care 2018
4720	Laboratuar	Nuzyra (amadacycline - Full prescribing infomation. Paratek Pharmaceuticals updated May 2021. Paratek Pharmaceuticals 2021

Mentions Légales